AzTrials
AzTrials

Mental DisordersNCT07087730

Improving Patient Mental Health With Psychotherapist Virtual Training

A study testing Virtual Training Program, Training as Usual and No Training in people with Mental Disorders, run by University of Ottawa at 1 site in Canada.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Several types of psychotherapy are equally effective to treat mental disorders. However, many patients remain symptomatic after treatment. The investigators demonstrated that a professional development training program to improve psychotherapists' skills at identifying and repairing therapeutic alliance tensions… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Mental Disorders
What is being tested?
Virtual Training Program, Training as Usual and No Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
489 participants
Where
1 siteCanada
Study dates
2 Aug 2023to 1 May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Therapist participants: The investigators will recruit mental health professionals who deliver psychotherapy in North American community settings; inclusion criteria: therapists are in good standing with their provincial or state regulatory college, their scope of practice includes individual psychotherapy for adults in North America; they are able to accept a minimum of 3 new participating patients into their current practice to conduct 6 consecutive therapy sessions via a secure, PHIPA compliant virtual meeting platform.
  • Patient Participants: Adults (> 18 years) residing in Canada or the United States who want to engage in therapy with a study therapist or who have recently sought services from a study therapist; inclusion criteria: have participated in fewer than 3 sessions with their study therapist and anticipate being able to see their study therapist for 6 sessions over the next 6 months.

Who cannot join

  • Therapist participants: The investigators will exclude therapists who are employed by an organization if the investigators cannot obtain organizational approval from their employer or coordinate data collection from an alternate virtual platform in instances where the employing organization does not permit the use of the study platform. Therapists will also be excluded if they have completed professional development workshop after 2017 with PPRNet.
  • Patient participants: The investigators will exclude patients if they: (a) have a psychotic or neurocognitive disorder that may preclude engagement in psychotherapy, (b) are in concurrent psychological treatment with another practitioner, (c) are at high risk of suicide or suicidal behaviors as assessed by their therapist (e.g., suicide attempt or hospitalization for suicidal behaviors in the past 6 months), or (d) for whom the therapist judge that approaching them with information about the study will be harmful.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Canada1 site, 1 recruiting
  • University of Ottawa

    Ottawa, Ontario, K1N 6N5

    Stephanie B, PhD, 6135625800 ext. 4218, sbake3@uottawa.ca

    Recruiting

Other trials in Canada

About this study

Official title: Improving Patient Mental Health With Psychotherapist Virtual Training: A Practice- Research Network Study

Several types of psychotherapy are equally effective to treat mental disorders. However, many patients remain symptomatic after treatment. The investigators demonstrated that a professional development training program to improve psychotherapists' skills at identifying and repairing therapeutic alliance tensions resulted in improved therapeutic alliance (an important therapeutic ingredient) and patient mental health outcomes. However, the investigators delivered this training program by conventional in-person workshops which limited access by psychotherapists living outside large urban centres. Further, post-study interviews with therapists suggested that cultural/diversity factors complicated the therapeutic alliance.

In the current study, the investigators will test the effectiveness and acceptability of a virtually-delivered training program to psychotherapists in North America to improve their capacity to identify and repair problems in the therapeutic alliance, including tensions related to patient diversity. The investigators will also examine how acceptable the virtually-delivered training is to psychotherapists and whether they would use such training in their practice. Participants in the study will be community-based licensed psychotherapists and their patients engaging in therapy in North America. Patient mental health outcomes, therapeutic alliance, and diversity issues will be assessed by comparing outcome measures between three groups: 1) therapists complete a self-paced virtual course + consultation, 2) therapists complete synchronous workshop + consultation, 3) control: therapists do not complete training.

The team of investigators developed Canada's largest psychotherapy practice-research network and has expertise in clinical trials, diversity, and education research of virtual training. State of the art training is often out of the reach of therapists who live outside of urban centres, and the effectiveness and acceptability of providing training virtually is not well-studied in mental health care. This study will improve psychotherapists' effectiveness at managing the therapeutic alliance and issues related to diversity, and will improve patient mental health outcomes thus promising to reduce the burden of mental illness.

Being tested
Virtual Training Program, Training as Usual, No Training
Keywords
Psychotherapists, Psychotherapy, Outcome Assessment, Healthcare, Cultural Diversity, Humans, Mental Disorders, Telemedicine
Medical subject headings
Mental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Training ProgramBehavioural

    Therapists randomized to this condition will receive the professional development via an asynchronous virtual training course. The Virtual Training will include written material, videos, interactive learning activities, and a text-based discussion forum where therapists and faculty will be able to interact in relation to the given activities. Clinical scenario and simulation-based interactive learning will allow therapists to explore clinical situations, make decisions, and evaluate consequences of their actions in a safe environment. Therapists will complete 6 study-related therapy sessions with 3 new patients. After therapists receive the Virtual Training and after they enroll their first patient, therapists will attend bi-weekly 1-hour online consultation meetings that include up to 6 therapists at a time and led by two of the training faculty. Each therapist will attend 10 of these posttraining consultation sessions.

  • Training as UsualBehavioural

    Therapists randomized to this condition will receive the professional development training via a 3-day synchronous workshop delivered via video conference covering the same didactic content as the virtual training course. The workshop will include lectures, written material, videos, and live role play activities. Therapists will complete 6 study-related sessions with 3 new patients. After therapists receive the professional development through Training as Usual and after they enroll their first patient, therapists will attend bi-weekly 1-hour online consultation meetings that include up to 6 therapists at a time and led by two of the training faculty. Each therapist will attend 10 of these posttraining consultation sessions.

  • No TrainingBehavioural

    Therapists randomized to this control condition will provide psychotherapy via the study video conference platform to 3 new enrolled patients in their typical manner except that they and their patients will also complete the assessments necessary for the study. After study completion, the investigators will provide therapists in the control condition with access to virtual training.

Study groups in NCT07087730
Study groupRoleWhat they receive
Virtual Training ProgramExperimentalAsynchronous virtual training professional development program including consultation.
Receives: Behavioral: Virtual Training Program
Training as UsualActive comparatorSynchronous virtual workshop professional development including consultation.
Receives: Behavioral: Training as Usual
No TrainingActive comparatorNo training, therapy as usual.
Receives: Behavioral: No Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Working Alliance Inventory (WAI) therapist or patient short form

    12-item self-report measure used to assess the therapeutic alliance by either therapist or client. Yields scores on three subscales: task, bond, and goal. Min subscale score is 12, max score is 84 with higher scores indicate greater alliance.

    Measured: Patients and therapists will complete it after each of 6 consecutive study psychotherapy session (frequency will range from once a week to once a month depending on the client's typical session interval).

  2. Ruptures Resolution Rating System (3RS)

    Observer-based coding system for identifying therapeutic alliance ruptures and resolutions.

    Measured: Sessions will be coded by trained raters after all session recordings have been collected.

Secondary outcomes (21)
  1. Patient Health Questionnaire (PHQ-9)

    Self-report measure used to assess depressive symptoms. Min score is 0; max score is 27 with higher scores indicating greater severity of depressive symptoms.

    Measured: Patients will complete it before starting study psychotherapy sessions, after completing all study sessions (6 weeks to 6 months depending on the client's typical session interval), and at 3-month follow-up.

  2. Generalized Anxiety Disorder questionnaire (GAD-7)

    Self-report measure used to assess anxiety symptoms. Min score is 0; max score is 21 with higher scores indicating higher levels of anxiety symptoms.

    Measured: Patients will complete it before starting study psychotherapy sessions, after completing all study sessions (6 weeks to 6 months depending on the client's typical session interval), and at 3-month follow-up.

  3. Inventory of Interpersonal Problems (IIP-32)

    Self-report measure used to assess interpersonal problems. This 32-item measure yields 8 subscales with a min score of 0 and a max score of 15 per scale with higher scores indicating greater interpersonal problems.

    Measured: Patients will complete it before starting study psychotherapy sessions (6 weeks to 6 months depending on the client's typical session interval), after completing all study sessions, and at 3-month follow-up.

  4. Defense Mechanism Rating Scales (DMRS-SR-30)

    Self-report measure used to assess defense mechanisms. Total score can range from 0 to 120 with low scores indicate low adaptive functioning and higher scores indicate better adaptive functioning.

    Measured: Patients will complete it before starting study psychotherapy sessions, after completing all study sessions (6 weeks to 6 months depending on the client's typical session interval), and at 3-month follow-up.

  5. Experiences in Close Relationships (ECR-12)

    Self-report measure used to assess two dimensions of attachment: attachment avoidance and anxiety. Scores on each scale can range from 6 to 42 with high scores indicating greater attachment avoidance or anxiety.

    Measured: Patients will complete it before starting study psychotherapy sessions and 3 months after completing therapy sessions. Therapists will completed it before receiving training.

  6. Certainty About Mental States Questionnaire (CAMSQ)

    Self-report measure used to assess a person's perceived capacity to understand oneself and others' mental states. Mean scores of subscales can range from 1 to 7 with higher mean scores indicating higher mentalization.

    Measured: Patients will complete it before starting study psychotherapy sessions.

  7. Multidimensional scale of perceived social support (MSPSS)

    Self-report measure used to assess perceived adequacy of support from family, friends, and significant others. The mean score on each subscale can range from 1 to 7 with higher scores indicating greater social support.

    Measured: Patients will complete it before starting study psychotherapy sessions.

  8. Rosenberg Self-Esteem Scale (RSES)

    Self-report measure used to assess self-esteem. Total score can range from 0 to 30 with higher scores indicating higher self esteem.

    Measured: Patients will complete it before starting study psychotherapy sessions.

  9. Epistemic Trust, Mistrust, and Credulity Scale (ETMCQ)

    Self-report measure used to assess epistemic trust on three subscales: trust, mistrust, and credulity. Mean scores on each subscale ranges from 1 to 35 with higher scores indicating greater trust.

    Measured: Patients will complete it before starting study psychotherapy sessions.

  10. Outcome Rating Scale (ORS)

    4-item visual analogue scale used to assess global functioning for the previous week by indication their position on a rating line on 4 scales: personal wellbeing, family/close relationships, work/school/friendships; overall. Scores can be examined for each item that can create a total score for all items that can range between 0 to 40. Higher scores indicate higher functioning.

    Measured: Patients and therapists will complete it after each of 6 consecutive study psychotherapy session (frequency will range from once a week to once a month depending on the client's typical session interval).

  11. Schwartz Outcome Scale (SOS-10).

    Self-report measure used to assess well-being. A total score across items can range from 0 to 60 with higher scores representing greater psychological well-being and lower scores indicating emotional distress and poorer psychological health.

    Measured: Patients will complete it before starting study psychotherapy sessions, after each study-related therapy session (over 6 weeks to 6 month period), and at 3-month follow-up; therapists will complete it after each study session (6 weeks to 6 months).

  12. Multitheoretical List of Therapeutic Interventions (MULTI-30)

    Self-report measure used to assess therapeutic interventions used in psychotherapy sessions. Weighted mean scores on 8 intervention subscales are calculated with a range of 1 to 5. Higher scores indicate intervention approaches that are very typical with lower scores indicating less typical.

    Measured: Therapists and patients will complete respective versions of the measure after completing all study therapy sessions (6 weeks to 6 months after the first study session depending on the frequency of study session).

  13. Real Relationship Inventory (RRI)

    Self-report measure used to assess the therapeutic relationship. Two subscales, realism and genuineness combined to generate a total score. Total scores range from 24 to 120 with higher scores indicating stronger relationship.

    Measured: Therapists and patients will complete respective versions of the measure after completing all study therapy sessions.

  14. Patient drop-out

    Unilateral withdrawal from treatment by a patient at any time during the study will indicate a negative outcome. The investigators will monitor whether drop out occurred early (<5 sessions) or late (>5 sessions).

    Measured: Patient drop-out will be monitored throughout the study.

  15. Certainty About Mental States Questionnaire (CAMSQ)

    Self-report measure used to assess a person's perceived capacity to understand oneself and others' mental states. Mean scores of subscales can range from 1 to 7 with higher mean scores indicating higher mentalization.

    Measured: Therapists will complete the measure before and after receiving training.

  16. Trauma-informed Care Provider Survey (TICPS)

    Self-report measure used to assess healthcare providers' knowledge, opinions, and competence related to trauma-informed care. Total score subscales are as follows: knowledge, can range from 13 - 52; opinions toward trauma-informed, can range from 7-28; competence can range from 0-24. with higher scores indicating more knowledge, opinions favourable to trauma-informed care, and competence.

    Measured: Therapists will complete the measure before and after receiving training.

  17. Gay Affirmative Practice Scale (GAP)

    Self-report measure used to assess practitioners' engagement with gay-affirmative practices on two subscales; beliefs and behaviour. Scores on the each subscale can range from 15 to 75 with higher total across subscales reflecting more affirmative practice with gay and lesbian clients.

    Measured: Therapists will complete the measure before and after receiving training.

  18. Multicultural Counseling Self-Efficacy Scale

    Self-report measure used to assess therapists' perceived ability to counsel culturally diverse patients. A mean total scale score is calculated, ranging from 0 to 9, with higher scores indicating stronger multicultural counseling capabilities.

    Measured: Therapists will complete the measure before and after receiving training.

  19. Psychologist and Counselor Self-Efficacy Scale (CASES)

    Self-report measure used to assess therapists' professional self-efficacy on three domains: basic helping skills, session tasks, and challenging counseling situations and presenting issues with scores ranging from 0 to 135 with greater scores indicating greater perceived efficiency.

    Measured: Therapists will complete the measure before and after receiving training.

  20. Adverse Childhood Experiences - Philadelphia version (Philly-ACES)

    Self-report measure used to assess the number of adverse childhood experiences across 14 categories. The number of adverse experiences across categories is summed and participants are given one of the following scores: 0, 1-2, or 3+ Adverse Childhood Experiences.

    Measured: Patients will complete it before starting study psychotherapy sessions.

  21. Trauma Symptom Discrimination Scale (TSDS)

    Self-report measure used to assess distress and anxiety symptoms due to the experience of discrimination. A total score is calculated by adding up the scores from all items and can range from 21 to 84 with higher scores indicating higher distress due to experiences of discrimination.

    Measured: Patients will complete it before starting study psychotherapy sessions.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jul 2025
  2. Study start2 Aug 2023
  3. Primary completion5 Dec 2026 (estimated)
  4. Study completion1 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
3-arm, prospective, single blind randomized controlled trial with 2-1-1 allocation comparing (i) Virtual training, (ii) training as usual, (iii) no training.
Masking
Single blind
Who is masked
Participant
Enrolment
489 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07087730
Sponsor's protocol ID
156261
Other IDs
461713
Status last verified
Jul 2025
First submitted
23 Apr 2024
Last updated
28 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Training Program, Training as Usual and No Training in people with Mental Disorders, run by University of Ottawa at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 28 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Giorgio A Tasca, PhD (1-613-562-5800 ext. 3890, gtasca@uottawa.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Working Alliance Inventory (WAI) therapist or patient short form (time frame: Patients and therapists will complete it after each of 6 consecutive study psychotherapy session (frequency will range from once a week to once a month depending on the client's typical session interval).). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in